title: A review of stroke and pregnancy: incidence, management and prevention.
abstract: Stroke, defined as a focal or global disturbance of cerebral function lasting over 24h resulting from disruption of its blood supply, is a devastating event for a pregnant woman. This can result in long-term disability or death, and impact on her family and unborn child. In addition to pre-existing patient risk factors, the hypercoagulable state and pre-eclampsia need to be taken into account. The patterns and types of stroke affect pregnant women differ from the non-pregnant female population of child-bearing age. Like other thrombo-embolic diseases in pregnancy, stroke is essentially a disease of the puerperium. Population studies have estimated the risk of stroke at between 21.2 and 46.2 per 100,000. The US Nationwide Inpatient Sample, identified 2850 pregnancies complicated by stroke in the United States in 2000-2001, for a rate of 34.2 per 100,000 deliveries. There were 117 deaths, a mortality rate of 1.4 per 100,000. Both the mortality and disability rates were higher than previously reported, with 10-13% of women dying. With the increasing prevalence of obesity, hypertension and cardiac disease amongst women of child-bearing age, so is the incidence of stroke during pregnancy and the puerperium. In the United States, an alarming trend toward higher numbers of stroke hospitalizations during the last decade was demonstrated in studies from 1995 to 1996 and 2006 to 2007. The rate of all types of stroke increased by 47% among antenatal hospitalizations, and by 83% among post-partum hospitalizations. Hypertensive disorders, obesity and heart disease complicated 32% of antenatal admissions and 53% of post-partum admissions. In addition to pre-existing patient risk factors, the hypercoagulable state and pre-eclampsia need to be taken into account. The patterns and types of stroke affect pregnant women differ from the non-pregnant female population of child-bearing age. Like other thrombo-embolic diseases in pregnancy, stroke is essentially a disease of the puerperium.
authors.affiliation: Specialist Registrar Obstetrics and Gynaecology, Whipps Cross University Hospital, Whipps Cross Road, London E11 1NR, United Kingdom. Electronic address: zmoatti@gmail.com.
authors.forename: Zoe
authors.initials: Z
authors.lastname: Moatti
authors.affiliation: Consultant Obstetrician and Gynaecologist and Subspecialist in Maternal and Fetal Medicine, Barts and The Royal London NHS Trust, Whipps Cross University Hospital, Whipps' Cross Road, London E11 1NR, United Kingdom.
authors.forename: Manish
authors.initials: M
authors.lastname: Gupta
authors.affiliation: Consultant Physician, Stroke Specialist, Barts and The Royal London NHS Trust, Whipps Cross University Hospital, Whipps' Cross Road, London E11 1NR, United Kingdom.
authors.forename: Rajendra
authors.initials: R
authors.lastname: Yadava
authors.affiliation: Consultant Obstetrician and Gynaecologist at The Royal London Hospital, Barts and The Royal London NHS Trust, Whipps Cross University Hospital, Whipps' Cross Road, London E11 1NR, United Kingdom.
authors.forename: Sujatha
authors.initials: S
authors.lastname: Thamban
mesh_terms: D002545:Brain Ischemia / Q000150:complications*; D005260:Female; D005343:Fibrinolytic Agents / Q000627:therapeutic use; D006801:Humans; D015994:Incidence; D020300:Intracranial Hemorrhages / Q000150:complications*; D009765:Obesity / Q000453:epidemiology; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011225:Pre-Eclampsia / Q000453:epidemiology; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000175:diagnosis / Q000453:epidemiology* / Q000209:etiology / Q000628:therapy*; D012307:Risk Factors; D020521:Stroke / Q000175:diagnosis / Q000453:epidemiology* / Q000209:etiology / Q000628:therapy*
chemical_list: D005343:Fibrinolytic Agents; D010975:Platelet Aggregation Inhibitors
keywords: High-risk pregnancy; Pre-eclampsia; Stroke; Thrombolysis